|
Although still a relatively new Society, (founded November 2004), the ISCTM has established itself as a vital and important forum for addressing significant issues that influence the development of treatments for patients with CNS Disorders. With financial and intellectual support from Industry, Academic members and Regulatory agencies, the ISCTM has already hosted eight conferences and two satellite meetings where key stakeholders have gathered for the purpose of identifying the challenges and opportunities that confront all of us as we try to make an important difference in the life of the patient. We uniquely tackle thorny and topical issues, by emphasizing in-depth discussion, consensus building, and recommendations for action that lead to solutions. To date, ISCTM has been able to provide this service primarily through the unrestricted support of pharmaceutical industry sponsors. However, one of the basic tenets of the society is to remain independent from any commercial interest. In order to maintain this independence and achieve all our goals, we need your individual support through membership in this society. Besides the satisfaction of knowing you have made a contribution to your field by supporting the mission of the ISCTM, below are tangible Benefits of Membership:
We look forward to you joining our community of scientists, clinicians, regulators, and educators. Please feel free to contact the Secretariat with any questions or feedback. |